Back to News
Sep 26, 2025 4:00 PM

Amgen Expands US Manufacturing Network Amid New Tariff Policy

Just when the Trump administration announced a 100% tariff on pharmaceuticals starting in October, Amgen Inc (NASDAQ: AMGN) announced a $650 million expansion of its U.S. manufacturing network.

The announcement builds on Amgen’s recent investments, including a $600 million science and innovation center in California and manufacturing expansions of $900 million in Ohio and $1 billion in North Carolina, respectively.

The planned investment will support increased drug production at the company’s biologics manufacturing facility in Juncos and integrate advanced technologies throughout the operations process.

Also Read: Trump’s New Tariff ...